PANCREATIC SECRETORY TRYPSIN-INHIBITOR IN GASTROINTESTINAL MUCOSA AND GASTRIC-JUICE

被引:37
作者
FREEMAN, TC
PLAYFORD, RJ
QUINN, C
BEARDSHALL, K
POULTER, L
YOUNG, J
CALAM, J
机构
[1] ROYAL POSTGRAD MED SCH,DEPT MED,GASTROENTEROL UNIT,DU CANE RD,LONDON W12 0NN,ENGLAND
[2] ICI PHARMACEUT PLC,BIOTECHNOL,MACCLESFIELD,CHESHIRE,ENGLAND
[3] ICI PHARMACEUT PLC,BIOSCI,MACCLESFIELD,CHESHIRE,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1136/gut.31.11.1318
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We studied the distribution of pancreatic secretory trypsin inhibitor (PSTI) in the epithelia of the gastrointestinal tract and determined whether PSTI is secreted into gastric juice. PSTI was measured by a specific radioimmunoassay in biopsy specimens taken from the upper (n = 8) and lower (n = 7) gastrointestinal tract of patients with normal endoscopies. PSTI was present in the stomach, small intestine, and colon. Concentrations (μg/g protein) were highest in the stomach, and significantly higher in the antrum (1240, 670-1700, median and range) than in the gastric body (370, 350-570) (p < 0.01). Concentrations were similar in the duodenum (180, 80-210) and colon (160, 130-360). PSTI determined by immunohistochemistry was present in mucus secreting gastric foveolar cells, duodenal Paneth cells, and colonic non mucus cells. PSTI was present in gastric juice. The median (range) concentration of PSTI in basal gastric juice from 13 patients with duodenal ulcers was 9 (3-21) μg/l and did not change during stimulation with pentagastrin. The rate of secretion, however, did increase significantly (p < 0.05) from 1430 (180-2810) ng/h to 4500 (1250-12770) ng/h during pentagastrin stimulation. PSTI was labile in acid pepsin but stable in the neutral conditions present in the mucus layer. The presence of pancreatic secretory trypsin inhibitor throughout the gut and its secretion into the lumen suggests a hitherto unrecognised mechanism protecting gastrointestinal epithelia against luminal proteases.
引用
收藏
页码:1318 / 1323
页数:6
相关论文
共 26 条
  • [1] VARYING OCCURRENCE OF GASTRODUODENAL IMMUNOREACTIVE PANCREATIC SECRETORY TRYPSIN-INHIBITOR
    BOHE, M
    LINDSTROM, CG
    OHLSSON, K
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (11) : 1345 - 1348
  • [2] FATE OF ORALLY INGESTED ENZYMES IN PANCREATIC INSUFFICIENCY COMPARISON OF 2 DOSAGE SCHEDULES
    DIMAGNO, EP
    MALAGELADA, JR
    GO, VLW
    MOERTEL, CG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (23) : 1318 - 1322
  • [3] DONOVAN I, 1984, TXB GASTROENTEROLOGY, P105
  • [4] FLEMSTORM G, 1987, PHYSL GASTROINTESTIN, V2
  • [5] FREEMAN TC, 1989, GUT, V30, pA752
  • [6] IMMUNOHISTOCHEMICAL LOCALIZATION OF PANCREATIC SECRETORY TRYPSIN-INHIBITOR IN FETAL AND ADULT PANCREATIC AND EXTRAPANCREATIC TISSUES
    FUKAYAMA, M
    HAYASHI, Y
    KOIKE, M
    OGAWA, M
    KOSAKI, G
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1986, 34 (02) : 227 - 235
  • [7] Greene L J, 1976, Methods Enzymol, V45, P813
  • [8] HUANG S, 1976, LAB INVEST, V35, P383
  • [9] EPIDERMAL GROWTH-FACTOR - INTERNAL DUPLICATION AND PROBABLE RELATIONSHIP TO PANCREATIC SECRETORY TRYPSIN-INHIBITOR
    HUNT, LT
    BARKER, WC
    DAYHOFF, MO
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 60 (03) : 1020 - 1028
  • [10] HUNTER WM, 1962, NATURE, V194, P494